[17] 于志强，李月彬，黄传新，等. 中国人常染色体遗传的病理性近视基因定位[J]. 中华眼科杂志，2007，43(3):233-238.

[18] 史铭宇，张帆，邱辉，等. 曲安奈德在玻璃体切割术中的应用[J].国际眼科杂志，2006，6(4):943-944.

[19] Horio N, Horiguchi M. Effect on visual outcome after macular hole surgery when staining the internal limiting membrane with Indocyanine Green Dye[J]. Arch Ophthalmol，2004，122(7):992-996.

[20] Goldbaum MH, McCuen BW, Hanneken AM， et al. Silicone oil tamponade to seal macular holes without position restrictions[J]. Ophthalmol，1998，105（11）:2140-2148.

[21] Lai JC， Stinnett SS, McCuen BW, et al. Comparison of silicone oil versus gas tamponade in the treatment of idiopathic full-thickness macular hole[J]. Ophthalmol，2003，110（6）:1170-1174.

[22] Arevalo JF, Rodriquez FJ, Rosales-Meneses JL, et al. Vitreoretinal surgery for macular hole after laser assisted in situ keraomileusis for the correction of myopia[J]. Br J Ophthalmol，2005，89（11）:1423-1426.

[23] Benhamou N, Massin P, Haouchine B, et al. Macular retinoschisis in highly myopic eyes[J]. Am J Ophthalmol，2002，133（6）:794-800.

[24] 王文吉. 病理性近视黄斑病变的诊治[J]. 眼科，2006，15(4):220-222.

[25] 黄欣，赵培泉，王文吉，等. 高度近视眼中心凹脱离伴视网膜劈裂的形态学观察[J]. 眼科，2006，15(4):237-239.

[26] Ikuno Y, Tano Y. Vitrectomy for macular holes associated with myopic feveoschisis[J]. Am J Ophthalmol，2006，141（4）:774-776.

[27] Baba T, Ohno-Matsui K, Futagami S, et al. Prevalence and characteristics of foveal retinal detachment without macular hole in higy myopia[J]. Am J Ophthalmol，2003，135（3）:338-342.

[28] Panozzo G, Mercanti A. Optical coherence tomography findings in myopic traction maculopathy[J]. Arch Ophthalmol，2004，122(10):1455-1460.

[29] Kanda S, Uemura A, Sakamoto Y, et al. Vitrectomy with internal limiting membrane peeling for macular retinoschisis and retinal detachment without macular hole in highly myopic eyes[J]. Am J Ophthalmol，2003，136(1):177-180.

[30] Ikuno Y, Sayanagi K, Ohji M, et al. Vitrectomy and internal limiting membrane peeling for myopic foveoschisis[J]. Am J Ophthalmol，2004，137（4）:719-724.

[31] 欧杰雄，李梅，于强，等. 高度近视眼荧光素眼底血管造影与吲哚青绿血管造影分析[J]. 中华眼底病杂志，2003，19(2):87-89.

[32] Pece A, Isola V, Vadala M, et al. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization secondary to pathologic myopia[J]. Retina，2006，26（7）:746-751.

[33] Rogério A, Costa RA, Williams GA, et al. Twofold illumination photodynamic therapy scheme for subfoveal choroidal neovascularization in pathologic myopia-results from a randomized pilot study[J]. Retina，2006，26（7）:757-764.

[34] Eyetech Study Group. Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration:Phase 2 study results[J]. Ophthalmology，2003，110（5）:979-986.

[35] Gehlbach P, Demetriades AM, Yamamoto S, et al. Periocular injection of adenoviral vector encoding pigment epithelium-derived factor inhibits choroidal neovascularization[J]. Gene Ther 2003，10（8）:637-646.

[36] Messmer EM, Heidenkummer HP, Kampik A. Ultrastructure of epiretinal membranes associated with macular holes[J]. Graefes Arch Clin Exp Ophthalmol，1998，236(4):248-254.

[37] 张皙，王方. 黄斑表面膜的分层结构[J]. 中华眼底病杂志，2001，17(1):52-54.

[38] Freund KB, Yannuzi LA. Peripapillary inferior myopic retinal crescent[R]． Poster presented at：Association for Research in Vision and Ophthalmology Annual Meeting；May 14,1995；Fort Lauderdale. Fla.

[39] Shimada N, Ohno-Matsui K, Yoshida T, et al. Characteristics of peripapillary detachment in pathologic myopia[J]. Arch Ophthalmol，2006，124(1):46-52.

[40] 姚毅，姜荔，陈伟民. 病理性近视眼继发视盘周围视网膜脱离的临床分析[J]. 国际眼科杂志，2006，6(4):758-761.

[41] 唐建明，刘南琳，吴乃川. 后巩膜加固术治疗病理性近视的临床体会[J]. 临床眼科杂志，2006，14(4):324-326.

[42] 刘乔. 后巩膜加固术远期效果观察[J]. 眼视光学杂志，1999， 1(2):83-85.

[43] 戴淑真，曾骏文，王丽娅. 哌仑西平对鸡形觉剥夺性近视的疗效及作用机制[J]. 中华眼科杂志，2006，42（1）:42-47.

上一页  [1] [2] [3]